Of course, as Elon Musk is a finite resource, Twitter's loss is Tesla's gain.
SGEN is a biotech with leadership precisely where big pharma wants to go.
The FOMC flat out tells us here that they are willing to damage the economy in order to get a handle on and tamp down consumer-level inflation.
The technical signs are suggesting that the shares of the software provider could weaken.
This particular biotech company just saw its stock whacked but still holds a lot of promise.
Shares of the DVD kiosk and streaming video company have spurted higher, but buyers are playing with fire.
The idea of a Netflix/Roku merger sounds less crazy than it would have before April.
As a busted BIRD bottoms, Billy Beane loses his 'seat' and a SOTP story continues a nice run.
There's a key price level to watch.
Let's review the charts and indicators.